| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d4b7a6ae1aaba28bba3b6d00cfd3ae4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97 |
| filingDate |
2006-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66b0176f322c1c3edece7a20a723f987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0810f6ae683eec61cf2d3e45c85b464e |
| publicationDate |
2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007308394-A |
| titleOfInvention |
Skin moisturizer and dermatitis treatment agent |
| abstract |
PROBLEM TO BE SOLVED: To provide a new dermatitis therapeutic agent / skin moisturizer which has few side effects and can be used for a long time. Disclosed is a dermatitis therapeutic agent / skin moisturizer containing ceramide-derived ceramide as an active ingredient. Ceramox-derived ceramide has two chemokines that play an important role in the development of dermatitis, namely, the chemokine CCL1 production inhibitory effect from Langerhans cells and the dermatitis-induced chemokine CCL27 production inhibitory effect from surface keratinocytes. Have. In addition, ceramide-derived ceramide exhibits a moisturizing action and a dermatitis onset suppressing action in dermatitis model mice. [Selection] Figure 2 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210064460-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102379555-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013522190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010053077-A |
| priorityDate |
2006-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |